Bristol-Myers Squibb (BMY) Tops Q2 EPS by 15c, Updates FY EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Bristol-Myers Squibb (BMY) Tops Q2 EPS by 15c, Updates FY EPS Guidance

Bristol Myers Squibb Reports Second Quarter 2020 Financial Results

August 6, 2020 6:59 AM EDT

Reports Second Quarter Revenues of $10.1 Billion Posts GAAP Loss Per Share of $0.04 and Non-GAAP EPS of $1.63 Advances Pipeline with Positive Topline Results for Zeposia in Ulcerative Colitis; Approvals for Opdivo plus Yervoy in Lung Cancer Updates 2020 GAAP EPS Guidance Range from $0.37-$0.57 to ($0.06)-$0.09 and Non-GAAP EPS Guidance Range from $6.00-$6.20 to $6.10-$6.25

NEW YORK--(BUSINESS... More